Drug: PEMETREXED Injury: Ocular hyperaemia Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
122335925 | PEMETREXED | Ocular hyperaemia | ROCHE | 66.48 YR | M | 0 | 20160707 | GB |
122485576 | PEMETREXED | Ocular hyperaemia | AMGEN | 66.00 YR | M | 0 | 20160713 | GB |
122618796 | PEMETREXED | Ocular hyperaemia | TEVA | 66.00 YR | M | 0 | 20160803 | GB |
122679664 | PEMETREXED | Ocular hyperaemia | FRESENIUS KABI | 66.00 YR | M | 0 | 20160728 | GB |
122684524 | PEMETREXED | Ocular hyperaemia | MYLAN | 0.00 | 0 | 20160729 | GB | |
122804695 | PEMETREXED | Ocular hyperaemia | ACCORD | 66.00 YR | M | 0 | 20160801 | GB |
Total Records: 6 Number of Pages: 1